Waverly Advisors LLC Grows Stake in CVS Health Corporation $CVS

Waverly Advisors LLC lifted its stake in CVS Health Corporation (NYSE:CVS) by 7.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 90,642 shares of the pharmacy operator’s stock after buying an additional 6,672 shares during the period. Waverly Advisors LLC’s holdings in CVS Health were worth $9,377,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. California State Teachers Retirement System grew its position in CVS Health by 10,133.9% in the second quarter. California State Teachers Retirement System now owns 193,320,429 shares of the pharmacy operator’s stock valued at $19,998,998,000 after acquiring an additional 191,431,405 shares in the last quarter. BlackRock Inc. purchased a new stake in CVS Health during the 2nd quarter worth $12,747,462,000. State Street Corp lifted its holdings in CVS Health by 2.1% in the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after buying an additional 1,245,457 shares in the last quarter. Wellington Management Group LLP boosted its position in CVS Health by 49.8% in the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock valued at $3,496,725,000 after buying an additional 11,233,381 shares during the last quarter. Finally, Capital International Investors grew its stake in shares of CVS Health by 3.4% during the fourth quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after acquiring an additional 900,153 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Performance

CVS Health stock opened at $95.43 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company has a fifty day moving average price of $100.31 and a two-hundred day moving average price of $90.61. The company has a market cap of $122.05 billion, a PE ratio of 25.25, a P/E/G ratio of 0.94 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same period in the prior year, the company earned $1.81 earnings per share. The firm’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Recent coverage highlighted CVS Health’s improving business performance and financial results. The company’s latest reported quarter included adjusted earnings of $2.58 per share, above the $1.87 analyst consensus, while revenue increased 7.3% year over year. CVS has issued fiscal 2026 earnings guidance of $7.90–$8.10 per share. Wall Street Loves CVS Health Stock Right Now. Should You?
• Positive Sentiment: Zacks identified CVS as a strong momentum stock, while increased investor attention could support near-term trading interest. These assessments are based largely on quantitative and sentiment factors rather than a new company announcement. Here’s Why CVS Health Is a Strong Momentum Stock
• Neutral Sentiment: CVS marked the 20th anniversary of its free community health-screening program. A company-commissioned survey found that nearly one in four U.S. adults has delayed contacting a health professional because of access, cost or availability barriers, while one-third were unaware of community screening programs. The initiative may support CVS’s community-health reputation but is unlikely to materially affect near-term earnings. CVS Health Community Health Screening Program
• Negative Sentiment: CVS flagged elevated medical expenses, raising concerns about profit margins and earnings visibility across its managed-care operations. The warning pressured the broader managed-care group and is the clearest near-term reason for weakness in CVS stock. CVS Health Flags Elevated Medical Expenses

Analysts Set New Price Targets

A number of research analysts recently commented on CVS shares. Truist Financial increased their price target on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Morgan Stanley upped their target price on CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. Piper Sandler set a $112.00 price target on shares of CVS Health in a research report on Wednesday. Wall Street Zen raised shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Finally, Robert W. Baird set a $107.00 price objective on shares of CVS Health in a report on Thursday, August 6th. Twenty-two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $107.24.

About CVS Health

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.